
Summary
- Constellation Brands has declined 41% in 12 months and is now trading at a 26% forward P/E discount to the sector median.
- STZ faces significant top- and bottom-line growth headwinds, with expansion expected to resume in FY 2026.
- Berkshire Hathaway’s 7.7% stake offers some long-term reassurance, but near-term outperformance is unlikely.
- I rate STZ stock a hold with a $150 price target, implying 9% upside …

Summary
- Constellation Brands has declined 41% in 12 months and is now trading at a 26% forward P/E discount to the sector median.
- STZ faces significant top- and bottom-line growth headwinds, with expansion expected to resume in FY 2026.
- Berkshire Hathaway’s 7.7% stake offers some long-term reassurance, but near-term outperformance is unlikely.
- I rate STZ stock a hold with a $150 price target, implying 9% upside excluding dividends.
Jonathan Knowles/DigitalVision via Getty Images
Constellation Brands (STZ) is an international beer, wine, and spirit producer that has experienced a 41% decline in the stock price over the past 12 months. The company presents a defensive approach, dividend income, and above-market margins, which may help
This article was written by

1.17K Followers
**Analyst’s Disclosure:**I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.